The Lung Cancer Screening Gap Is an Operational Problem
Lung cancer remains the leading cause of cancer death in the United States, accounting for more deaths annually than breast, colon, and prostate cancers combined, according to the American Lung Association. The U.S. Preventive Services Task Force recommends annual low-dose CT (LDCT) screening for high-risk individuals aged 50–80 with a significant smoking history — a guideline supported by evidence showing a 20% reduction in lung cancer mortality in screened populations.
Yet as of 2025, the American Lung Association's State of Lung Cancer report found that only 18% of eligible individuals are currently participating in screening. This gap is not primarily a clinical problem — it is an operational and outreach problem. Eligible patients are not being identified systematically, outreach is inconsistent, scheduling is fragmented, and result communication often fails to close the loop with patients and referring providers.
Virtual assistants (VAs) trained in lung cancer screening program operations are helping programs address each of these operational failures at scale.
High-Risk Patient Identification and Outreach
The first function where VAs add measurable value in lung cancer screening programs is systematic outreach to eligible patients. Using EHR data exports or registry queries, VAs contact patients who meet USPSTF eligibility criteria but have not been screened, or who are overdue for their annual follow-up scan. This outreach — conducted by phone, text, or patient portal message — is labor-intensive when performed consistently across a large panel, but essential for moving screening rates.
VAs trained in shared decision-making scripts support pre-screening conversations, documenting that the patient has been counseled on the benefits, limitations, and potential harms of screening as required before a Medicare-covered LDCT can be ordered. Without this documented SDM visit, the screening claim will be denied — a common and preventable revenue loss in programs that do not have dedicated staff managing the eligibility and documentation workflow.
LDCT Scheduling and Insurance Navigation
Once a patient is identified as eligible and a shared decision-making visit is completed, scheduling the LDCT involves insurance verification, prior authorization for commercial plans that require it, imaging center coordination, and patient preparation instruction delivery. Programs that operate within hospital systems may face additional scheduling complexity across multiple imaging sites.
VAs managing LDCT scheduling verify coverage eligibility and determine whether prior authorization is required under the patient's specific plan. For Medicare beneficiaries, the LDCT is covered without prior auth when properly documented — but the documentation requirements are specific and frequently incomplete in primary care referrals. VAs identify and remediate documentation gaps before claims are submitted, reducing denials that slow program throughput.
Result Communication: The Critical Continuum Function
Result communication is where many lung cancer screening programs lose patients from the continuum. Lung-RADS scoring — the standardized result classification system for LDCT findings — assigns patients to follow-up categories ranging from 12-month rescreening to immediate diagnostic workup. Getting the right message to the patient and the referring provider in a format they can act on is an administrative function with life-or-death stakes.
Lung cancer screening VAs manage result communication workflows: contacting patients by phone with result summaries, sending portal-accessible reports, routing high-risk results (Lung-RADS 4A/4B/4X) to the pulmonologist or thoracic surgery team for urgent follow-up scheduling, and confirming that the referring provider has received the radiologist's report. Programs that implement structured result communication protocols show higher rates of recommended follow-up adherence — directly improving early-stage detection rates.
Tracking and Quality Metrics
Accredited lung cancer screening programs must report on quality metrics including screening rates, follow-up adherence, and cancer detection rates. VAs maintain the tracking infrastructure for these metrics: updating patient status in the screening registry, flagging patients who are lost to follow-up, and generating data exports for quarterly reporting.
This quality infrastructure, while not directly reimbursed, is essential for maintaining accreditation, qualifying for value-based program bonuses, and demonstrating program effectiveness to health system administrators.
Lung cancer screening programs looking to expand administrative capacity can partner with healthcare-focused VA providers. Stealth Agents provides screening programs with VAs experienced in LDCT scheduling, shared decision-making documentation, result communication workflows, and screening registry management.
Closing the Gap Is an Operational Priority
With an estimated 7.2 million Americans currently eligible for lung cancer screening but not participating (American Lung Association, 2025), the programs that invest in operational infrastructure to systematically engage, schedule, and follow up with high-risk patients will drive the mortality improvement that LDCT screening's clinical evidence promises. Virtual staffing is the scalable operational lever that makes this achievable.
Sources
- American Lung Association, State of Lung Cancer Report, 2025
- U.S. Preventive Services Task Force, Lung Cancer Screening Recommendations, 2025
- Centers for Medicare and Medicaid Services, LDCT Coverage and Documentation Requirements, 2025
- Lung-RADS, American College of Radiology, Version 1.1 Update, 2025
- National Lung Screening Trial Research Team, NEJM Results, cited in CDC 2025 data